Product Code: ETC6185791 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The myomectomy market in Australia is driven by the rising number of women diagnosed with uterine fibroids, a condition that often leads to symptoms such as heavy menstrual bleeding, pelvic pain, and infertility. Myomectomy, a surgical procedure to remove fibroids while preserving the uterus, is becoming a popular option for women who wish to maintain fertility. As awareness of this treatment option increases, more women are opting for minimally invasive techniques such as laparoscopic and robotic-assisted myomectomy. The market is expected to grow due to the rising demand for effective and safe treatment options for fibroids, as well as advancements in surgical technology that improve patient outcomes and recovery times.
The myomectomy market in Australia is growing due to increasing awareness and advancements in minimally invasive surgical techniques. Myomectomy, which involves the removal of fibroids from the uterus, is gaining popularity as an alternative to hysterectomy, as it allows women to retain their fertility. There is a marked trend towards the adoption of robotic surgery and laparoscopic procedures, which offer quicker recovery times, less pain, and reduced risk of complications. Additionally, the growing demand for fertility-preserving procedures, as well as an increasing number of women opting for later pregnancies, is driving the myomectomy market`s growth in Australia.
In the Australia myomectomy market, challenges include the complexity and risks associated with the surgical procedure. While it is considered a preferred treatment for uterine fibroids, it is not always suitable for all patients, especially those with larger fibroids or those who wish to preserve fertility. The surgery is also costly, and there are concerns regarding post-operative recovery and potential complications. Advances in minimally invasive techniques, such as laparoscopic and robotic surgeries, offer promise but remain underutilized due to high costs and the need for specialized equipment and training.
Australia myomectomy market offers attractive prospects driven by advancements in minimally invasive surgical techniques and growing awareness about uterine health. The demand for robotic-assisted and laparoscopic procedures is increasing, creating opportunities for investment in surgical equipment, specialized training centers, and post-operative care services. Additionally, collaborations with medical device manufacturers and private womens health clinics can yield substantial returns.
Myomectomy, being a surgical procedure to remove uterine fibroids, is funded under Medicare and public hospital systems, making it accessible through both public and private healthcare facilities. The Department of Health and Aged Care supports guidelines around womens reproductive health, which include recommendations for fibroid management. The government`s reproductive health campaigns and initiatives also indirectly support market growth through education and access to surgical interventions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Myomectomy Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Myomectomy Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Myomectomy Market - Industry Life Cycle |
3.4 Australia Myomectomy Market - Porter's Five Forces |
3.5 Australia Myomectomy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Myomectomy Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 Australia Myomectomy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Myomectomy Market Trends |
6 Australia Myomectomy Market, By Types |
6.1 Australia Myomectomy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Myomectomy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Myomectomy Market Revenues & Volume, By Abdominal Myomectomy, 2021- 2031F |
6.1.4 Australia Myomectomy Market Revenues & Volume, By Hysteroscopic Myomectomy, 2021- 2031F |
6.1.5 Australia Myomectomy Market Revenues & Volume, By Laparoscopic Myomectomy, 2021- 2031F |
6.2 Australia Myomectomy Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Australia Myomectomy Market Revenues & Volume, By Laparoscopic Power Morcellators, 2021- 2031F |
6.2.3 Australia Myomectomy Market Revenues & Volume, By Harmonic Scalpel, 2021- 2031F |
6.2.4 Australia Myomectomy Market Revenues & Volume, By Laparoscopic Sealer, 2021- 2031F |
6.2.5 Australia Myomectomy Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Myomectomy Market Import-Export Trade Statistics |
7.1 Australia Myomectomy Market Export to Major Countries |
7.2 Australia Myomectomy Market Imports from Major Countries |
8 Australia Myomectomy Market Key Performance Indicators |
9 Australia Myomectomy Market - Opportunity Assessment |
9.1 Australia Myomectomy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Myomectomy Market Opportunity Assessment, By Product, 2021 & 2031F |
10 Australia Myomectomy Market - Competitive Landscape |
10.1 Australia Myomectomy Market Revenue Share, By Companies, 2024 |
10.2 Australia Myomectomy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |